Methotrexate restores the function of peripheral blood regulatory T cells in psoriasis vulgaris via the CD73/AMPK/mTOR pathway

Is psoriasis an autoimmune disease? Interpretations from an immunofluorescence-based study

(2017) Shashi Anand et al.   JOURNAL OF CUTANEOUS PATHOLOGY

Critical role of environmental factors in the pathogenesis of psoriasis

(2017) Jinrong Zeng et al.   JOURNAL OF DERMATOLOGY

Should methotrexate remain the first-line drug for psoriasis?

(2017) Dafna D Gladman   LANCET

Fructose-1,6-bisphosphate and aldolase mediate glucose sensing by AMPK

(2017) Chen-Song Zhang et al.   NATURE

Risankizumab versus Ustekinumab for Moderate-to-Severe Plaque Psoriasis

(2017) Kim A. Papp et al.   NEW ENGLAND JOURNAL OF MEDICINE

Methotrexate up-regulates ecto-5′-nucleotidase/CD73 and reduces the frequency of T lymphocytes in the glioblastoma microenvironment

(2016) Fabrício Figueiró et al.   Purinergic Signalling

Characterization of Th17 and FoxP3+Treg Cells in Paediatric Psoriasis Patients

(2016) L. Zhang et al.   SCANDINAVIAN JOURNAL OF IMMUNOLOGY

Environmental Risk Factors in Psoriasis: The Point of View of the Nutritionist

(2016) Luigi Barrea et al.   International Journal of Environmental Research and Public Health

Pustular psoriasis-like lesions associated with hereditary lactate dehydrogenase M subunit deficiency without interleukin-36 receptor antagonist mutation: long-term follow-up of two cases

(2015) T. Ito et al.   BRITISH JOURNAL OF DERMATOLOGY

Autoimmune diseases and celiac disease which came first: genotype or gluten?

(2015) Antonella Diamanti et al.   Expert Review of Clinical Immunology

Clinical improvement in psoriasis with specific targeting of interleukin-23

(2015) Tamara Kopp et al.   NATURE

Methotrexate Restores Regulatory T Cell Function Through Demethylation of the FoxP3 Upstream Enhancer in Patients With Rheumatoid Arthritis

(2015) Adam P. Cribbs et al.   Arthritis & Rheumatology

Target tissue ectoenzyme CD39/CD73-expressing Foxp3+regulatory T cells in patients with psoriasis

(2014) H. Y. Zhang et al.   CLINICAL AND EXPERIMENTAL DERMATOLOGY

Immunological and histological evaluation of clinical samples from psoriasis patients treated with anti-CD6 itolizumab

(2014) Lazaro E Aira et al.   mAbs

Treg/IL-17 Ratio and Treg Differentiation in Patients with COPD

(2014) Yang Jin et al.   PLoS One

IL-17 drives psoriatic inflammation via distinct, target cell-specific mechanisms

(2014) H.-L. Ha et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Therapeutics: Silencing psoriasis

(2012) James Mitchell Crow   NATURE

CD73: a potent suppressor of antitumor immune responses

(2012) Paul. A. Beavis et al.   TRENDS IN IMMUNOLOGY

CD73 on Tumor Cells Impairs Antitumor T-Cell Responses: A Novel Mechanism of Tumor-Induced Immune Suppression

(2010) D. Jin et al.   CANCER RESEARCH

Increased Th17 cells are accompanied by FoxP3+ Treg cell accumulation and correlated with psoriasis disease severity

(2009) Li Zhang et al.   CLINICAL IMMUNOLOGY

Psoriasis Vulgaris Lesions Contain Discrete Populations of Th1 and Th17 T Cells

(2008) Michelle A. Lowes et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY